Healthcare Management Administrators (HMA) 2/20/2025

Proving What’s Possible in Healthcare This document contains important terms and conditions which are incorporated by reference into and becomes part of the terms of your contract with us. ©2024, Healthcare Management Administrators, Inc. 4. (Continued) MRx may contract with and/or utilize the services of a rebate aggregator to contract with and collect rebates from pharmaceutical manufacturers. The aggregator may retain a portion of the rebates and earn administrative fees for its services. In addition to Rebates, MRx may earn additional amounts from pharmaceutical manufacturers and/or others. For example, MRx may earn administrative and/or service fees relating to administration of the Rebate program, and fees for other services rendered by MRx to such manufacturers unrelated to the administration of rebates, such as adherence and compliance programs, other patient support and similar services. MRx Affiliates may also receive purchase discounts relating to purchases of drugs for dispensing from the Mail Order Pharmacy or Specialty Pharmacy. The amounts described in this paragraph are not “Rebates” under this Agreement. All pricing in this document is available to our new clients that become Sponsor Groups on and after the effective date of this document and to existing Sponsors on the effective date. If a Sponsor terminates either their PBM contract thru us or terminates with us altogether, and has passed runout, the Sponsor will be responsible for paying directly to MagellanRx any Medicare or Medicaid claims that are billed up to three (3) years after date of service. The pricing terms in this Agreement are based in part upon the Benefit Design (including but not limited to the Formulary), and other information provided by Sponsors or us to MRx during the proposal process. If a Sponsor makes any changes to the Benefit Design, makes other changes to its Plan(s), or if five percent (5%) of Claims are incurred collectively in Massachusetts, Hawaii, Alaska, Georgia, and Puerto Rico, or other changes occur, that constitute a material departure from MRx’s underwriting assumptions, including any relating to the mix of 350B Claims or those based on information provided by Sponsors or us, the Parties agree to modify the terms of this pricing as of the effective date of such event/change to return MRx to its relative economic position prior to such event/change. In the event Sponsor terminates Administrative Services Agreement with us, we may use pharmacy rebates as a set-off against amounts due to us from Sponsor or may delay remittance of these rebates to allow for final adjustments. Sponsor acknowledges that MagellanRx provides an administrative credit to us in compensation for the services provided including enrollment processing, invoice processing and customer service among other duties. We have credited the Medical Administration fee under this acknowledgement. We have also has considered the receipt of this administrative allowance in the calculation of the Plan’s TPA fees. In the event a change in Law (including any interpretation of same) occurring after this Agreement has been signed materially impacts MRx’s costs of providing any of the PBM Services hereunder, or if an action by a pharmaceutical manufacturer, any unscheduled patent expiration/availability of over-the-counter products, a drug withdrawal or recall, or industry-wide market change constitutes a material departure from MRx’s underwriting assumptions, the Parties will make an equitable modification to the pricing terms of this Schedule B as of the effective date of such event/change. In the event o f any increase in postage or carrier rates announced after this Agreement is signed, MRx will amend the Dispensing Fee relating to the Mail Order Pharmacy or Specialty Pharmacy, as applicable, to reflect such increased amount. 32 Pharmacy Benefits Additional fees, pricing, terms and Conditions as follows are for Sponsors on our contract and are effective January 2025 –December 2025.